Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations
|
|
- Amice Wilkins
- 5 years ago
- Views:
Transcription
1 British Journal of Anaesthesia 2015, doi: /bja/aev226 Review Articles REVIEW ARTICLES Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations M. Mahmoud 1, * and K. P. Mason 2 1 Department of Anesthesiology, Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA, and 2 Department of Anesthesiology, Perioperative, and Pain Medicine, Boston Children s Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA *Corresponding author. mohamed.mahmoud@cchmc.org Abstract Despite lack of paediatric labelling, contributions to the literature on paediatric applications of dexmedetomidine have increased over recent years. Dexmedetomidine possesses many properties that are advantageous for a sedative and anaesthetic; it has been reported to provide sedation that parallels natural sleep, anxiolysis, analgesia, sympatholysis, and an anaesthetic-sparing effect with minimal respiratory depression. In addition, there is increasing evidence supporting its organprotective effects against ischaemic and hypoxic injury. These favourable physiological effects combined with a limited adverse effect profile make dexmedetomidine an attractive adjunct to anaesthesia (general and regional) for a variety of procedures in paediatric operating rooms. A comprehensive understanding of the pharmacological, pharmacokinetic, and pharmacodynamic effects of dexmedetomidine is critical to maximize its safe, efficacious, and efficient paediatric perioperative applications. This review focuses on the current paediatric perioperative and periprocedural applications of dexmedetomidine and its limitations, with a consideration for the future. Key words: adverse events; anaesthesia; paediatric; pharmacology; sedation Editor s key points In this review, the authors describe the pharmacology of dexmedetomidine and review the background literature. They detail the applications in the paediatric perioperative context, outline the limitations of its use, and discuss the potential future applications. The ideal anaesthetic for perioperative application would be fast in onset and offset, with limited lipid solubility, predictable in response, easy to titrate, reliable in achieving a targeted level of sedation, able to preserve airway tone, and sparing of respiratory effects. This ideal agent would be neuroprotective and exhibit minimal cardiovascular effects. Unfortunately, such an ideal agent does not exist. Dexmedetomidine (DEX; Precedex ;Hospira, Lake Forest, IL, USA; and Dexdor; Orion Corporation, Espoo, Finland) possesses some of the desirable properties mentioned. In rodents and humans, DEX, through action on α 2 -adrenergic receptors in the locus coeruleus, provides relatively fast onset of sedative properties paralleling natural sleep, with minimal respiratory depression. 1 7 In some studies, DEX has been shown to be neuroprotective, reducing apoptosis in animals and humans To date, DEX has no known active or toxic metabolites. Currently, it is United States Food and Drug Administration (FDA) approved in the USA for sedation via i.v. bolus and continuous infusion for up to 24 h on intubated adults and for adult procedural sedation in areas The Author Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please journals.permissions@oup.com 171
2 172 Mahmoud and Mason outside the intensive care unit (ICU) and operating room setting. In Europe, it is approved for adults (intubated or non-intubated) in the ICU via continuous i.v. infusion, at higher doses than approved in the USA, and without a restriction on duration of administration. Currently, worldwide, there is no approval for administration to the paediatric population. 12 Despite the lack of paediatric labelling, DEX for paediatric use has been described for almost a decade in the literature. The favourable physiological effects of DEX combined with its limited adverse effect profile have facilitated its introduction into the perioperative setting. The α 2 -adrenergic effects of DEX, relative contraindications, and biphasic effect on blood pressure in both children and adults should be well understood by any provider who administers or cares for a patient receiving DEX. This review focuses on the diverse and most recent applications of DEX in the perioperative period in the paediatric population. We will summarize its current use as a premedication for anxiolysis, as an adjunctive drug both during and after surgery, and as an adjunct to attenuate emergence agitation, postoperative pain, and shivering. We will also discuss the clinical limitations, challenges, and relative contraindications to its use. A summary of the current paediatric perioperative and periprocedural applications of DEX and the varying dosing regimens, doses, and routes of administration are provided in Tables 1 and 2, respectively. Preoperative applications: anxiolysis Anxiolysis before the induction of anaesthesia is an important aspect of paediatric perioperative planning. Currently, there is a growing interest in comparing efficacy, time to onset, and outcomes between the different available anxiolytics. As a premedication, administration of DEX has been described by i.m., 13 intranasal, 14 and buccal routes. 15 Via the nasal and buccal routes, DEX bioavailability approximates 65% (35 93%) and 81.8% ( %), respectively The bioavailability of DEX by the oral route is very poor (16%), and in the authors opinion, administration by such a route is unwarranted. 16 When used as a premedication in paediatric patients, intranasal DEX has been shown to confer an advantage over both buccal DEX (1 μg kg 1 )andoralmidazolam(0.5mgkg ). Higher intranasal doses of DEX (2 rather than 1 μgkg 1 ) are more efficacious at producing sedation, anxiolysis, better acceptance to a mask inhalation induction, and less cardiovascular variability. 14 Doses of 1 μgkg 1 intranasal DEX produced a median onset of sedation of 25 min and median duration of 85 min in healthy children undergoing elective surgery. 20 At a higher dose, intranasal DEX 2 μg kg 1 (compared with oral midazolam 0.5 mg) produced faster onset of sedation without a demonstrable difference in conditions at induction, emergence, and recovery. 21 In a prospective, Table 1 Current common perioperative and periprocedural applications of dexmedetomidine in children Application Preoperative applications Anxiolysis Intraoperative applications Airway procedures Rigid bronchoscopy Drug-induced sleep endoscopy Magnetic resonance imaging sleep studies Open thyroplasty Anterior mediastinal mass biopsy Difficult intubation Neurosurgical procedures Posterior spine fusions Brain tumour and epileptic seizure foci resection Cardiac surgery Painful procedures Extracorporeal shock-wave lithotripsy Burn dressing change Lumbar puncture Bone marrow biopsy Central venous line placement Chest tube insertion Applications to benefit the recovery period Adenotonsillectomy Postoperative shivering Postoperative emergence agitation Advantage Easy and quick arousal from sedation Minimal respiratory depression Attenuates sympathetic haemodynamic response Obtunds airway reflexes while maintaining stable haemodynamic and respiratory profiles in spontaneously ventilating children Provides sedative properties paralleling natural sleep Lowers requirements for propofol and inhalation agents Facilitates intraoperative wake-up tests Preserves epileptiform activity Allows comfortable and cooperative sedation Blunts sympathetic response, provides analgesia and sedation in the postoperative period, and expedites extubation Combining ketamine and dexmedetomidine in these procedures provides sedation, analgesia, amnesia, and haemodynamic stability May reduce the incidence of severe emergence agitation, opioid requirements, and episodes of oxygen desaturation in children with obstructive sleep apnoea
3 Dexmedetomidine: review, update, and future considerations 173 Table 2 Summary of various dosing regimens and routes of administration for perioperative dexmedetomidine Application Route Dose range Preoperative applications Anxiolysis Buccal 1 μg kg 1 Intranasal μg kg 1 Intraoperative applications Airway procedures I.V. Loading dose: μg kg 1 over 10 min followed by an infusion of μg kg 1 h 1 Neurosurgical procedures Posterior spine fusions I.V μg kg 1 h 1 (a target plasma concentration of 0.4 ng ml 1 ) Brain tumour and epileptic seizure I.V μg kg 1 h 1 Cardiac surgery I.V. 0.5 μg kg 1 bolus and 0.5 μg kg 1 h 1 infusion Applications to benefit the recovery period Adenotonsillectomy I.V μg kg 1 Postoperative shivering I.V. 0.5 μg kg 1 Postoperative emergence agitation I.V μg kg 1 randomized, open-label clinical trial, children were enrolled into one of three groups of premedication: midazolam 0.5 mg kg 1 p. o., clonidine 4 μg kg 1 p.o., or transmucosal DEX 1 μg kg 1.All treatments produced similar anxiolysis, ease of separation from parents, recovery, and discharge time. Dexmedetomidine had advantages (compared with midazolam) with respect to analgesia and attenuation of the sympathetic haemodynamic response. 22 A recent meta-analysis of 13 randomized controlled trials on non-i.v. (intranasal, sublingual, or oral) DEX vs midazolam was performed to examine the efficacy in improving perioperative sedation and analgesia and in reducing postoperative agitation when used as a pre-anaesthetic medication in 1033 children. The authors concluded that DEX as a premedication is superior to midazolam in ensuring satisfactory levels of sedation in children undergoing surgery, both at separation from parents and at emergence. 23 This is in contrast with the findings of a recent meta-analysis that compared the use of DEX and midazolam as premedication in 829 children; this study did not show any superiority of DEX in ensuring satisfactory levels of sedation at induction of anaesthesia. 24 The major limitations of both studies are the significant heterogeneity between studies in the scales and measures used for sedation and evaluation of children s anxiety, differences in the anaesthesia protocols, and differences in the doses. The future of using DEX as a premedication is not clear. Dexmedetomidine is characterized by an easy and quick arousal from sedation resembling natural sleep, which makes it theoretically a promising premedication. In cotrast, its slow onset makes it an unsuitable substitute for oral midazolam. 24 More prospective randomized controlled trials are still required to identify theoptimaldosesandappropriatemonitoringofdexusefor premedication. Intraoperative applications Airway procedures Airway procedures, rigid bronchoscopy in particular, can be challenging because they often involve patients who are respiratory compromised, have apnoea (obstructive or central), may be an aspiration risk, and may require spontaneous ventilation for the benefit of the procedure and diagnosis. Total i.v. propofol anaesthesia, with or without remifentanil, is a common technique. Challenges with this technique include the ability to maintain spontaneous respiration, protect the airway (a particular concern in patients with aspiration risk), and prevent laryngospasm. Comparatively, DEX offers some advantages; in contrast to other agents, DEX converges on sleep pathways at the locus coeruleus and is associated with changes in neuronal activity similar to those seen in deeper stages of non-rapid eye movement sleep, without significant respiratory depression. The ability to maintain spontaneous ventilation and airway tone makes DEX an attractive consideration, particularly for children with severe preoperative airway impairment Previous reports have demonstrated that for rigid bronchoscopy, DEX offers advantages of obtunding airway reflexes while maintaining stable haemodynamic and respiratory profiles in spontaneously ventilating children Even at higher than recommended doses (3 μg kg 1 h 1 ), DEX maintains airway patency and tone, even in children with obstructive sleep apnoea, making it an ideal choice for sleep endoscopy and dynamic airway imaging Both sleep endoscopy and dynamic airway imaging favour techniques that mimic physiological sleep and avoid any airway interventions (including oral and nasal airways) that alter the child s natural physiological and clinical condition Dexmedetomidine has also been described for other airway procedures, including open thyroplasty with vocal cord medialization, a treatment of dysphonia. To optimize surgical repair, the patients need to be awake or lightly sedated during the procedure. The anaesthesia challenges require that the non-intubated patient has adequate anxiolysis, sedation, and analgesia while maintaining the ability to phonate on command. Dexmedetomidine has also been shown to be a valuable aid for other airway procedures, during which it, in combination with local anaesthetic, has maintained spontaneous ventilation and patient cooperation during laryngoplasty. 36 Incorporating and expanding the applications of DEX into appropriate paediatric airway surgeries will be invaluable, as it has already been successfully implemented for children at risk of airway collapse or a difficult airway By maintaining spontaneous ventilation and avoiding respiratory depression, DEX has been useful for those at risk of suffering fatal cardiopulmonary, respiratory, and cardiovascular complications. 40
4 174 Mahmoud and Mason Neurosurgical procedures Dexmedetomidine has been used as an adjunct to total i.v. anaesthesia in the perioperative regimen of posterior spine fusions, lowering the propofol and sevoflurane requirements and facilitating intraoperative wake-up tests A target plasma concentration of DEX 0.4 ng ml 1 and propofol 2.5 μgml 1 seems to have minimal effect on motor-evoked potentials. Higher plasma DEX concentrations, however, may attenuate the amplitude of motorevoked potentials. 43 Dexmedetomidine ( μg kg 1 h 1 ) can also be used as an adjunct to establish and maintain controlled hypotension (mean arterial blood pressure of mm Hg) during anterior spinal fusion. 44 Its concomitant effect, when used for controlled hypotension, on cardiac function, cerebral blood flow, and cerebral perfusion pressure has not been carefully evaluated. Brain mapping and neurophysiological testing have recently become an integral part of many neurosurgical techniques; in particular, brain tumour and epileptic seizure foci resection. The anaesthetic regimen requires anaesthesia during the craniotomy, followed by an awake, comfortable, and cooperative patient during lesion resection in order to provide near-instantaneous neurological feedback. The challenge is to achieve an adequate anaesthetic depth without untoward incidents of airway obstruction, respiratory depression, hypercapnia, coughing, or hypotension. Dexmedetomidine μg kg 1 h 1 maintains respiratory drive and airway patency while still enabling the child to be awakened and responsive to verbal stimulation for functional brain mapping. 45 Dexmedetomidine preserves epileptiform activity in children with seizure disorders, facilitating localization and identification of seizure foci There is literature to suggest that in adults it may be neuroprotective, also decreasing cerebral blood flow in proportion to a decrease in cerebral metabolic rate. 47 Cardiac surgery α 2 -Adrenergic agonists have been used in the perioperative period for adult and paediatric cardiac surgery in order to blunt the sympathetic response, provide analgesia and sedation in the postoperative period, maximize neurocognitive function, and expedite extubation A recent retrospective study suggests that perioperative DEX administration during cardiac surgery in adults (vs no DEX) was associated with a decrease in postoperative delirium and 1 yr mortality. 51 In children (1 6 yr old) undergoing cardiac surgery, i.v. DEX (0.5 μgkg 1 bolus and 0.5 μgkg 1 h 1 infusion) attenuates the haemodynamic and neuroendocrine (epinephrine, norepinephrine, blood glucose, and plasma cortisol) responses at incision, sternotomy, and postbypass. 52 Whether there is a long-term benefit in reducing delirium and mortality in the paediatric population has yet to be determined. Dental procedures Dexmedetomidine administered by different routes has been trialled for adult and paediatric dental sedation Although the bioavailability of DEX is poor by the oral route, a prospective, triple-blind, randomized study compared the efficacy and safety of one of three doses of oral DEX (3, 4, and 5 μg kg 1 )combined withketamine(8mgkg 1 ) for paediatric dental sedation. Children who received the combination with DEX 5 μgkg 1 had faster onset, superior intra- and postoperative analgesia and exhibited an anterograde amnesia. 60 Regional anaesthesia Clonidine, another α 2 -adrenergic agonist, has been administered with regional anaesthesia (epidural, intrathecal, and peripheral nerve block) for decades. 61 Dexmedetomidine has recently been described with regional blocks in both adults and children. In adults, a meta-analysis of 16 randomized controlled trials including 1092 adults compared outcomes between DEX (intrathecal, epidural, or caudal) and bupivacaine or ropivacaine. Dexmedetomidine was found to decrease the pain and prolong the analgesia. Although there was an increased incidence of bradycardia in the DEX group, it was not associated with hypotension and did not warrant treatment. 62 Likewise, the combination of caudal DEX and bupivacaine (1 μg kg 1 and 2.5 mg kg 1, respectively) in children has been shown to decrease the sevoflurane requirements, incidence of emergence agitation, and requirement for adjuvant postoperative analgesics and to increase the duration of postoperative pain relief compared with bupivacaine alone. The addition of caudal DEX to bupivacaine did not affect the haemodynamic response. 63 Epidural DEX and clonidine produced similar analgesia, duration of action, and haemodynamic profile when used with bupivacaine (2.5 mg kg 1 )for lower abdominal surgery in children. 64 A recent meta-analysis concluded that the addition of DEX to a caudal anaesthetic provided an extended duration of postoperative pain relief in 328 paediatric patients. There was no statistically significant effect on haemodynamics and adverse events with the addition of DEX to the local anaesthetic. Subgroup analysis showed no advantage of caudal DEX at 2 μg kg 1 compared with 1 μg kg 1 in terms of analgesia. 65 Administration of DEX by the neuraxial route is off label, and the safety has not been established in humans. In animal models, perineural administration of DEX attenuated inflammation in the sciatic nerve by reducing inflammatory cytokine concentrations. 66 In rabbits, however, epidural DEX elicited what appeared to be a demyelination of oligodendrocytes in the white matter of the spinal cord. 67 Future studies are warranted in order to support or dispel the concerns regarding neurotoxicity of DEX. Caution should be exercised when DEX sedation is used in infants and neonates receiving epidural analgesia without support from external warming devices. Infants depend more on non-shivering thermogenesis than on shivering and vasoconstriction. Dexmedetomidine interferes with non-shivering thermogenesis and can create the potential for development of hypothermia as a result of inhibition of lipolysis by postsynaptic α 2 receptors. Recently, a 2-day-old neonate developed hypothermia (33 C axillary) and bradycardia that was unresponsive to atropine (75 beats min 1 )inthepostoperative period while being sedated with DEX and receiving epidural analgesia, without using external warming devices. 68 The infant s temperature was restored to 37.6 C within 3 h, without sequelae, after reducing DEX infusion and applying an external heat source. Dexmedetomidine applications for ambulatory procedures There is a paucity of literature describing DEX for ambulatory procedures, perhaps because its half-life and analgesic properties do not lend themselves to the fast pace (induction, emergence, and recovery) of most ambulatory schedules. Administration of DEX has been described for the pressure-equalizing myringotomy tube procedure, but without an advantage over the more common options of intranasal fentanyl or paracetamol. 69 Likewise, when used for upper gastrointestinal endoscopy in children, DEX was not found to offer any advantages either alone or in combination with propofol. 70
5 Dexmedetomidine: review, update, and future considerations 175 Dexmedetomidine for painful procedures Although well described and successful for sedation for nonpainful procedures, DEX has been largely unsuccessful in providing adequate analgesia when used alone for painful procedures. Dexmedetomidine i.v. with ketamine i.v. may be a successful combination, with relatively fast onset and amnesia, sedation, analgesia, and haemodynamic stability (Figs 1 and 2) This technique has been described in adults and children for extracorporeal shock-wave lithotripsy, 77 lumbar puncture, 78 bone marrow biopsy, burn dressing changes, chest tube insertion, and femoral cut-down for tunnelled central venous catheter placement. 81 In the animal model, DEX has been shown to have beneficial effects on the mitochondrial membrane in ischaemic rats. 82 If this quality extends to humans, DEX could offer advantages for use in children with mitochondrial disorders or those who require an i.v. technique because of risk of malignant hyperthermia. Perioperative applications to benefit the recovery period Emergence agitation, relatively common for paediatric ambulatory procedures, is associated with morbidity in the recovery period A recent meta-analysis found that α 2 -agonists (clonidine or DEX) given by the oral, i.v., or caudal route had a prophylactic effect in preventing emergence agitation in children anaesthetized with sevoflurane or desflurane. 85 Dexmedetomidine μg kg 1 can prevent and treat postoperative agitation in children Perioperative infusion of 0.2 μg kg 1 h 1 decreases the incidence and frequency of postoperative agitation in children after sevoflurane without prolonging the time to extubation or discharge. 89 Compared with placebo, DEX (0.5 and 1 μg kg 1 ) decreases the incidence of emergence agitation from 47.6 to 4.8%, albeit with a slightly prolonged emergence and time to extubation In comparison with fentanyl (1 μgkg 1 ), intraoperative DEX (2 μg kg 1 bolus followed by 0.7 μg kg 1 h 1 ) reduced the incidence of severe emergence agitation, the postoperative opioid requirements, and the episodes of desaturation in children with obstructive sleep apnoea after tonsillectomy and adenoidectomy. 90 The optimal method (duration over which DEX should be administered and route of administration) and dosing of DEX for emergence agitation has not been determined in children. A rapid bolus may be preferable to a prolonged bolus over 10 min. Rapid DEX administration (<5 s) of μg kg 1 i.v. has been described in children undergoing cardiac catheterization without haemodynamic consequence. 91 Whether this dosing, route, and rate of administration will be effective in treating emergence agitation without clinically significant haemodynamic effect warrants future investigation. Dexmedetomidine has been successful to treat postoperative shivering. The exact mechanism of this effect is unknown. In a prospective, non-randomized open-label study in 24 children (7 16 yr old), DEX 0.5 μg kg 1 i.v. permanently ablated postoperative shivering within 5 min. 92 Although intraoperative DEX has been reported to reduce opioid consumption in children, the opioid-sparing effects of DEX in children are still not completely understood. In adults, intraoperative DEX has been shown in a recent meta-analysis to decrease postoperative pain scores and morphine consumption. 93 A recent meta-analysis of 11 randomized controlled trials examined the effects of intraoperative DEX vs placebo or opioids on postoperative pain, analgesic consumption, and adverse events Heart rate (beats per minute) Heart rate changes with DEX and DEX+KET administration Heart rate, baseline Heart rate after DEX Heart rate after DEX+KET Mean arterial pressure (mm Hg) Mean arterial pressure changes with DEX and DEX+KET administration Mean arterial pressure, baseline Mean arterial pressure after DEX Mean arterial pressure after DEX+KET Fig 1 In this study, 22 children (aged 5 17 yr) undergoing electrophysiological study and ablation for supraventricular tachycardia were enrolled. Changes in heart rate with dexmedetomidine and dexmedetomidine+ketamine administration were measured. The increase in mean arterial pressure was associated with a significant decrease in heart rate after dexmedetomidine (P<0.001), followed by a return towards baseline after co-administration of ketamine (1 mg kg 1 ) followed by continuous infusion (1 mg kg 1 h 1 ; P=0.005). Haemodynamic and electrophysiological changes with dexmedetomidine and dexmedetomidine+ketamine administration were measured. Baseline denotes measurements obtained before administration of any study drug (time point 1), after dexmedetomidine denotes measurements obtained after dexmedetomidine administration (time point 2), and dexmedetomidine+ketamine denotes measurements obtained after dexmedetomidine and ketamine administration (time point 3). From Char and colleagues, 75 with permission. Fig 2 In this study, 22 children (aged 5 17 yr) undergoing electrophysiological study and ablation for supraventricular tachycardia were enrolled. Changes in mean arterial pressure (MAP) with dexmedetomidine and dexmedetomidine+ketamine administration were measured. A significant increase in MAP was seen compared with baseline after loading of dexmedetomidine (1 μg kg 1 ) followed by continuous infusion of dexmedetomidine (0.7 μg kg 1 h 1 ; P<0.001). This returned to baseline 5 min after co-administration of ketamine (1 mg kg 1 ) followed by continuous infusion (1 mg kg 1 h 1 ; P<0.001). Haemodynamic and electrophysiological changes with dexmedetomidine and dexmedetomidine+ ketamine administration were measured. Baseline denotes measurements obtained before administration of any study drug (time point 1), after dexmedetomidine denotes measurements obtained after dexmedetomidine administration (time point 2), and dexmedetomidine+ketamine denotes measurements obtained after dexmedetomidine and ketamine administration (time point 3). From Char and colleagues, 75 with permission.
6 176 Mahmoud and Mason in 434 children undergoing surgery. The study demonstrated that intraoperative use of DEX provided similar postoperative analgesia compared with intraoperative opioid use and better postoperative analgesia compared with placebo use. 94 In a double-blind controlled trial, children who received high doses of DEX (2 and 4 μg kg 1 i.v.) immediately after tracheal intubation had a lower opiate requirement and longer opiate-free interval in recovery than the group that received a single i.v. dose of fentanyl (1 or 2 μg kg 1 ). 95 Dexmedetomidine may be an option to minimize intraoperative narcotic use, particularly for tonsillectomies. Dexmedetomidine 1 μg kg 1 and morphine 100 μg kg 1 i.v. have exhibited comparable morphine-sparing effects and time to discharge readiness after tonsillectomy and adenoidectomy. 96 This opioid-sparing analgesic and recovery profile of DEX in children after tonsillectomy and adenoidectomies may be particularly advantageous in those at risk of postoperative apnoea or respiratory compromise. Precautions when using dexmedetomidine Clinicians should be familiar with the varied haemodynamic responses to DEX. In children, the extent of these haemodynamic variations is related to the serum concentrations. 3 At higher doses, with presumably higher serum concentrations, a biphasic response on blood pressure is observed. In general, at serum concentrations >1 μg litre 1, the blood pressure changes from a mild decrease from baseline to an elevation. 97 Although decreases in heart rate and a biphasic effect on blood pressure are observed with increasing doses of DEX, the literature supports that concurrent haemodynamic collapse or need for pharmacological resuscitation does not occur. Rather, a recent publication suggests that immediate action to treat bradycardia associated with α 2 -adrenergic agonists in children is required only if concomitant vital signs are abnormal, if bradycardia is caused by a serious primary bradyarrhythmia, or both. 98 The occurrence of hypotension can be attenuated by pretreatment with balanced salt solution boluses. 99 Bradycardia or a decrease in resting heart rate (up to a 30% decrease from baseline) is expected and should be considered as a predictable physiological response anticipated with DEX. The heart rate responses are rarely of clinical significance, and they do not usually warrant treatment Extreme bradycardia can occur if DEX is administered to a patient receiving digoxin, and syncope, probably from a vasovagal response, has been cited in the literature and in the package insert Although there are no absolute contraindications to DEX in the literature or package insert, the authors recommend that DEX be avoided or carefully considered before administration in children receiving digoxin, β-adrenergic blockers, calcium channel blockers, or other agents that predispose to bradycardia or hypotension. Caution should be exercised when administering anticholinergics to treat isolated DEX-associated bradycardia in children, because i.v. glycopyrrolate has been shown to elicit immediate, significant hypertension. 104 Electrocardiographic abnormalities as noted by R R prolongation and junctional escape rhythms at 2 μgkg 1, administered as a single dose, have been reported with DEX use. 6 The concomitant administration of DEX with medications that have negative chronotropic effects (propofol, pyridostigmine, succinylcholine, and remifentanil) may potentiate vagotonic or negative chronotropic effects. 42 Sinus arrest has been shown in a young healthy adult volunteer 3.5 h after DEX administration. 105 Asystole after atropine 0.5 mg to treat a heart rate in the 30s, was reported in a 52-yr-old woman receiving a DEX infusion during general anaesthesia (fentanyl, propofol, and sevoflurane). 106 Clinicians should be familiar with the haemodynamic responses associated with rapid loading or bolus administration of DEX. Although the labelling recommends loads be administered over 10 min, rapid boluses in small doses (0.25 and 0.5 μg kg 1 ) have been well tolerated in children undergoing cardiac catheterization with volatile anaesthetic after cardiac transplant. The denervation of the sinoatrial node, however, should be considered as a potential factor for the minimal observed response. 91 A recent study examined the dose response to a DEX bolus over 5 s administered to healthy children. The maximal elevation in mean arterial pressure was a 33% increase from baseline, and the maximal decrease in heart rate was 36% from baseline (Fig. 3). An ED 50 (no haemodynamic response in half the subjects) of 0.49 μg kg 1 was extrapolated to avoid haemodynamic responses in half the subjects. 107 Nevertheless, the authors do not condone off-label, rapid administration of DEX boluses until further literature is published to support the safety of this practice. There is limited information regarding the effect of DEX on the pulmonary vasculature and pulmonary vascular resistance (PVR) in children with varying degrees of pulmonary hypertension. In an animal model, DEX (2 μg kg 1 over 1 min) transiently increased mean pulmonary artery pressure and PVR. 108 Similar transient pulmonary haemodynamic changes have been shown in healthy adult volunteers subjected to increasing DEX infusions to a plasma concentration of 1.9 ng ml 1. 6 After cardiac surgery, DEX doses as permitted by labelling had minimal effect on the pulmonary artery pressure, leaving ventricular function unchanged. 109 The effect of DEX on infants and children with pulmonary hypertension can be variable. Children with HR (b-min 1 ) MAP (mm Hg) Hemodynamic response to dexmedetomidine bolus Time (min) Fig 3 In this study, 21 ASA I II children, median age 7.1 (range ) yr, were enrolled. The haemodynamic response to a dexmedetomidine bolus administered over 5 s was measured. The top plot shows the relative heart rate (HR) changes (in beats per minute), normalized to each patient s baseline value (0=baseline HR). Likewise, the relative mean noninvasive blood pressure (MAP) changes (in millimetres of mercury), normalized to each patient s baseline value (0=baseline MAP), are shown in the bottom plot. The raw data are superimposed by population percentiles (5th, 50th, and 95th centiles) in black lines, and measurements violating the +30 and 30% MAP and HR thresholds are highlighted with large grey dots. From Dawes and colleagues, 107 with permission.
7 Dexmedetomidine: review, update, and future considerations 177 pulmonary hypertension, compared with those without, both demonstrated no significant change in pulmonary vascular resistance, pulmonary artery pressure, and cardiac index in response to DEX bolus of up to 1 μgkg 1 followed by a continuous infusion of 0.7 μg kg 1 h In contrast, a recent FDA-monitored study evaluating the effect of DEX on PVR in children with pulmonary hypertension was terminated because of increased PVR in addition to premature ventricular complexes, bradycardia (<60 beats min 1 ), and hypotension in one of the subjects (Table 3). 111 Another prospective observational pilot study demonstrated that DEX after congenital cardiac surgery did not have a demonstrable effect on pulmonary artery pressure of children who did not have pulmonary hypertension. 109 Given the potential impact of these findings on infants and children with pre-existing pulmonary hypertension, future studies are warranted before advocating routine use of DEX in this patient population. End-organ effects of dexmedetomidine Effect of dexmedetomidine on the kidney Dexmedetomidine causes diuresis by reducing vasopressin secretion, enhancing renal blood flow and glomerular filtration, and increasing urine output Recent animal studies showed that it can also protect against radiocontrast nephropathy by preserving outer medullary renal blood flow. 114 One should also be aware of the potential development of polyuric syndrome when DEX is used. A recent case report in an adult patient who underwent posterior spinal fusion under general anaesthesia with isoflurane, and sufentanil, DEX, and lidocaine infusions showed that urine output increased from 150 to 950 ml h 1. An increasing serum sodium, low urine specific gravity, and increased serum osmolarity occurred simultaneously with the polyuria. Within 2 h of discontinuing the DEX infusion, urine output greatly decreased, and all signs of the polyuric syndrome resolved spontaneously in 24 h. 115 Despite the diuretic effect of DEX in adults, the 74% increase in urinary output that has been seen for up to 4 h after cardiac surgery does not affect renal function when compared with placebo in a double-blind design. 116 There are some data to support a renoprotective effect of DEX. A retrospective review of cardiac and thoracic surgeries in adults who received a DEX infusion of up to 0.6 μgkg 1 h 1 for up to 24 h after surgery revealed a decrease in 30 day mortality and decrease in serum markers for acute kidney injury. 117 Similar results were found in children who received i.v. iodine contrast for cardiac angiography. Compared with the control group, children 6 months to 6 yr of age had decreased elevation in plasma endothelin, renin, and markers of acute renal injury. 118 Future studies are warranted to delineate the patient population, surgical procedures, and resultant effect of DEX on renal function. Effect of dexmedetomidine on the brain There is no literature to date that describes the effect of DEX on memory acquisition, recall, and amnesia in children. The challenges associated with designing and successfully implementing such a trial in children may have limited the conducting of such studies. In adults though, DEX dosing has been associated with the depth of sedation and specific aspects of memory acquisition. With increasing serum concentrations of DEX, there is a decrease in the Observer Assessment of Alertness/Sedation (OASS) scale and visual analog scale. 119 With increasing plasma concentrations Table 3 Haemodynamic measurements in patients with pulmonary hypertension receiving dexmedetomidine for sedation. a PVR after correction of base deficit of 3 with bicarbonate. Dias BP, diastolic blood pressure; HR, heart rate; Mean BP, mean blood pressure; PVR, pulmonary vascular resistance; Sats, peripheral oxygen saturation; Sys BP, systolic blood pressure; T0, baseline; T1, after a dexmedetomidine bolus; T2, 30 min after a dexmedetomidine infusion Subject ID T0 PVR T1 PVR T2 PVR T0 Sats T1 Sats T2 Sats T0 T1 T2 T0 T1 T2 TO TI T2 T0 HR T1 HR T2 HR Sys BP Sys BP Sys BP Dias BP Dias BP Dias BP Mean BP Mean BP Mean BP a
8 178 Mahmoud and Mason % 50 Recalled * /10 8/10 4/10 0/10 0/6 0/4 0/1 # of subjects 10 completing step % 50 Recognized 25 * 10/10 10/10 5/10 2/10 1/6 0/4 0/1 0 Baseline Plasma dexmedetomidine (ng ml 1 ) last decade indicate that DEX exhibits long-term effects on the brain, including neuroprotection through α 2 -adrenergic receptors To date, only DEX and possibly xenon have been proposed to be safe. 127 Further research is warranted to examine the existence of associations between early anaesthetic exposure to DEX and long-term neurocognitive function. In conclusion, data regarding the perioperative off-label use of DEX in the paediatric population are promising but still limited, and further studies are required. The adverse event profile of benzodiazepines, propofol, and opioids, alone and in combination, leaves a window of opportunity to consider alternative agents that may improve outcome and minimize risk. Particularly in patients with respiratory compromise, for whom the preservation of spontaneous ventilation and airway tone is preferable, or those for whom the preservation of neuromonitoring with or without patient responsiveness is the goal, DEX should be seriously considered. An in-depth understanding of the pharmacological, pharmacokinetic, and pharmacodynamic effects of DEX is critical to maximize its safe use in paediatric perioperative applications. Fig 4 This study examined the responses to increasing plasma concentrations of dexmedetomidine (0.5, 0.8, 1.2, 2.0, 3.2, 5.0, and 8.0 ng ml 1 )in10healthymen(20 27 yr old). Recall and recognition decreased at a dose of more than 0.7 ng ml 1. The bar graph shows percentage of correct responses to the memory test at each infusion step. The number of subjects who correctly recalled or recognized the picture over the number of subjects participating in the test at each infusion step is indicated within the box in each bar (no. recalled/no. participating). Beginning with infusion step 4, the number of subjects who received dexmedetomidine no longer corresponds to the number of subjects who were shown a picture. The difference is the number of subjects who could not be aroused. Indicates that no pictures were shown at this step because both subjects who received this dose could not be aroused. *P<0.05, significant trend during dexmedetomidine infusions compared with baseline, Mantel Haenszel test. From Ebert and colleagues, 119 with permission. of DEX administered to healthy adult volunteers, the correct recall or recognition of a picture decreased (Fig. 4). 119 In adults, it has been suggested that on continuous-recognition tasks using photograph recognition to differentiate working from long-term memory, DEX impairs familiarity more than recognition. 120 Whether a similar response is seen in children has yet to be determined. Thus, until the effect of DEX on amnesia has been clarified, the authors suggest that synergistic administration of amnestic medications be administered if recall is unwanted. Future considerations There has been growing interest and support, as evidenced in the burgeoning literature over the past few years, that DEX can be beneficial in the paediatric perioperative period. Recently, its potential as being organ protective, albeit mostly for animals and at the bench-top level, poses promise for future studies and for valuable clinical applications in humans. One of the most interesting and valuable future directions of DEX research involves its potential for neuroprotection. Particularly in the paediatric population, the issue of anaesthetic-induced neurotoxicity has continued to gain attention and research support over the past decade, as some studies have suggested that inhalation and i.v. anaesthetics may both cause neurotoxicity The laboratory and animal studies in the Authors contributions Reviewing the relevant literature: M.M., K.M. Manuscript preparation: M.M., K.M. Approval of final manuscript and attestation to data integrity: M.M., K.M. Declaration of interest None declared. References 1. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an α2 agonist, is mediated in the locus coerüleus in rats. Anesthesiology 1992; 76: Petroz GC, Sikich N, James M, et al. AphaseI,two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The α2- adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anaesthetic action in rats via activation of central α2 adrenoceptors. Anesthesiology 1989; 71: Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: Akeju O, Pavone KJ, Westover MB, et al. A comparison of propofol- and dexmedetomidine-induced electroencephalogram dynamics using spectral and coherence analysis. Anesthesiology 2014; 121: Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand 2010; 54: Li Y, Zeng M, Chen W, et al. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/
9 Dexmedetomidine: review, update, and future considerations 179 Akt pathway in the hippocampus of neonatal rats. PloS ONE 2014; 9: e Tachibana K, Hashimoto T, Kato R, et al. Neonatal administration with dexmedetomidine does not impair the rat hippocampal synaptic plasticity later in adulthood. Paediatr Anaesth 2012; 22: Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009; 110: Mason KP, Lerman J. Review article: Dexmedetomidine in children: current knowledge and future applications. Anesth Analg 2011; 113: Karaaslan D, Peker TT, Alaca A, et al. Comparison of buccal and intramuscular dexmedetomidine premedication for arthroscopic knee surgery. J Clin Anesth 2006; 18: Wang SS, Zhang MZ, Sun Y, et al. The sedative effects and the attenuation of cardiovascular and arousal responses during anaesthesia induction and intubation in paediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine. Paediatr Anaesth 2014; 24: Cimen ZS, Hanci A, Sivrikaya GU, Kilinc LT, Erol MK. Comparison of buccal and nasal dexmedetomidine premedication for paediatric patients. Paediatr Anaesth 2013; 23: Anttila M, Penttilä J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003; 56: Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol 2011; 67: Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in paediatric anaesthesia: a double-blinded randomized controlled trial. Anesth Analg 2008; 106: Ghali AM, Mahfouz AK, Al-Bahrani M. Preanaesthetic medication in children: a comparison of intranasal dexmedetomidine versus oral midazolam. Saudi J Anaesth 2011; 5: Yuen VM, Hui TW, Irwin MG, Yao TJ, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia 2010; 65: Talon MD, Woodson LC, Sherwood ER, Aarsland A, McRae L, Benham T. Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery. J Burn Care Res 2009; 30: Schmidt AP, Valinetti EA, Bandeira D, Bertacchi MF, Simoes CM, Auler JO Jr Effects of preanaesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children. Paediatr Anaesth 2007; 17: Pasin L, Febres D, Testa V, et al. Dexmedetomidine vs midazolam as preanaesthetic medication in children: a metaanalysis of randomized controlled trials. Paediatr Anaesth 2015; 25: Sun Y, Lu Y, Huang Y, Jiang H. Is dexmedetomidine superior to midazolam as a premedication in children? A metaanalysis of randomized controlled trials. Paediatr Anaesth 2014; 24: Huupponen E, Maksimow A, Lapinlampi P, et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008; 52: Mason KP, O Mahony E, Zurakowski D, Libenson MH. Effects of dexmedetomidine sedation on the EEG in children. Paediatr Anaesth 2009; 19: Mahmoud M, Gunter J, Donnelly LF, Wang Y, Nick TG, Sadhasivam S. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg 2009; 109: Mahmoud M, Gunter J, Sadhasivam S. Cine MRI airway studies in children with sleep apnea: optimal images and anaesthetic challenges. Paediatr Radiol 2009; 39: Shukry M, Kennedy K. Dexmedetomidine as a total intravenous anaesthetic in infants. Paediatr Anaesth 2007; 17: Seybold JL, Ramamurthi RJ, Hammer GB. The use of dexmedetomidine during laryngoscopy, bronchoscopy, and tracheal extubation following tracheal reconstruction. Paediatr Anaesth 2007; 17: Chen KZ, Ye M, Hu CB, Shen X. Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. Br J Anaesth 2014; 112: Mahmoud M, Radhakrishman R, Gunter J, et al. Effect of increasing depth of dexmedetomidine anaesthesia on upper airway morphology in children. Paediatr Anaesth 2010; 20: Mahmoud M, Jung D, Salisbury S, et al. Effect of increasing depth of dexmedetomidine and propofol anaesthesia on upper airway morphology in children and adolescents with obstructive sleep apnea. J Clin Anesth 2013; 25: Truong MT, Woo VG, Koltai PJ. Sleep endoscopy as a diagnostic tool in paediatric obstructive sleep apnea. Int J Paediatr Otorhinolaryngol 2012; 76: Chatterjee D, Friedman N, Shott S, Mahmoud M. Anaesthetic dilemmas for dynamic evaluation of the paediatric upper airway. Semin Cardiothorac Vasc Anaesth 2014; 18: Abdelmalak B, Gutenberg L, Lorenz RR, Smith M, Farag E, Doyle DJ. Dexmedetomidine supplemented with local anaesthesia for awake laryngoplasty. J Clin Anesth 2009; 21: Tsai CJ, Chu KS, Chen TI, Lu DV, Wang HM, Lu IC. A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia 2010; 65: Stricker P, Fiadjoe JE, McGinnis S. Intubation of an infant with Pierre Robin sequence under dexmedetomidine sedation using the Shikani Optical Stylet. Acta Anaesthesiol Scand 2008; 52: Iravani M, Wald SH. Dexmedetomidine and ketamine for fiberoptic intubation in a child with severe mandibular hypoplasia. J Clin Anesth 2008; 20: Mahmoud M, Tyler T, Sadhasivam S. Dexmedetomidine and ketamine for large anterior mediastinal mass biopsy. Paediatr Anaesth 2008; 18: Tobias JD. Dexmedetomidine: applications in paediatric critical care and paediatric anesthesiology. Paediatr Crit Care Med 2007; 8: Peden CJ, Cloote AH, Stratford N, Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 2001; 56: Mahmoud M, Sadhasivam S, Salisbury S, et al. Susceptibility of transcranial electric motor-evoked potentials to varying
Dexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History
Dexmedetomidine Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai Dexmedetomidine is the most recently released IV anesthetic. It is a highly selective α 2 -adrenergic agonist
More informationCorresponding author: V. Dua, Department of Anaesthesia, BJ Wadia Hospital for Children, Parel, Mumbai, India.
Comparative evaluation of dexmedetomidine as a premedication given intranasally vs orally in children between 1 to 8 years of age undergoing minor surgical procedures V. Dua, P. Sawant, P. Bhadlikar Department
More informationDexmedetomidine, an 2 adrenergic agonist, was
Dexmedetomidine in Children: Current Knowledge and Future Applications Keira P. Mason, MD,* and Jerrold Lerman, MD, FRCPC, FANZCA More than 200 studies and reports have been published regarding the use
More informationASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG
ASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG PREAMBLE : EVOLUTION OF SEDATION IN THE ICU 1980s : ICU sedation largely extension of GA No standard approach, highly variable Deep
More informationA Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital
Original Research A Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital Kamala GR 1, Leela GR 2 1 Assistant Professor, Department of Anaesthesiology,
More informationInvasive and noninvasive procedures
Feature Review Article Dexmedetomidine and ketamine: An effective alternative for procedural sedation? Joseph D. Tobias, MD Objectives: Although generally effective for sedation during noninvasive procedures,
More informationUse of Dexmedetomidine for Sedation of Children Hospitalized in the Intensive Care Unit
ORIGINAL RESEARCH Use of Dexmedetomidine for Sedation of Children Hospitalized in the Intensive Care Unit Christopher L. Carroll, MD 1 Diane Krieger, MSN, CPNP 1 Margaret Campbell, PharmD 2 Daniel G. Fisher,
More informationSCIENTIFIC COOPERATIONS MEDICAL WORKSHOPS July, 2015, Istanbul - TURKEY
21-22 July, 2015, Istanbul - TURKEY PROSPECTIVE EVALUATION OF CORRELATION OF DEPTH OF DEXMEDETOMIDINE SEDATION AND CLINICAL EFFECTS FOR RECONSTRUCTIVE SURGERIES UNDER REGIONAL ANAESTHESIA Alma Jaunmuktane
More informationStudy between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation
Original Research Article Study between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation K. Selvarju 1, Kondreddi Narayana Prasad 2*, Ajay Kumar Reddy Bobba
More informationDOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol
1573 medetomidine a review of clinical applications J. Curr Opin Anaesthesiol 2008 21 4 457-461. 6 DAHMANI S PARIS A JANNIER V et al. Dexmedetom- 2. α 2 idine increases hippocampal phosphorylated extracellular
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 10 Mar 2019 06:52:14 GMT) CTRI Number Last Modified On 29/07/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationPropofol vs Dexmedetomidine
Propofol vs Dexmedetomidine A highlight of similarities & differences Lama Nazer, PharmD, BCPS Critical Care Clinical Pharmacy Specialist King Hussein Cancer Center Outline Highlight similarities and differences
More informationComparison of dexmedetomidine v/s propofol used as adjuvant with combined spinal epidural anaesthesia for joint replacement surgeries
Comparison of dexmedetomidine v/s propofol used as adjuvant with combined spinal epidural anaesthesia for joint replacement surgeries Kuldeep Chittora 1 *; Ritu Sharma 2 ; Rajeev LochanTiwari 3 1 Department
More informationAppendix: Outcomes when Using Adjunct Dexmedetomidine with Propofol Sedation in
SUPPLEMENTAL CONTENT Appendix: Outcomes when Using Adjunct Dexmedetomidine with Propofol Sedation in Mechanically Ventilated Surgical Intensive Care Patients Table of Contents Methods Summary of Definitions
More informationDexmedetomidine: its use in intensive care medicine and anaesthesia
BJA Education, 16 (7): 242 246 (2016) doi: 10.1093/bjaed/mkv047 Advance Access Publication Date: 26 September 2015 Matrix reference 1A02, 2C05, 2A10, 3C00 Dexmedetomidine: its use in intensive care medicine
More informationDıfferent Doses Of Dexmedetomidine On Controllıng Haemodynamıc Responses To Tracheal Intubatıon
ISPUB.COM The Internet Journal of Anesthesiology Volume 27 Number 2 Dıfferent Doses Of Dexmedetomidine On Controllıng Haemodynamıc Responses To Tracheal Intubatıon A Sa??ro?lu, M Celik, Z Orhon, S Yüzer,
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Domitor 1 solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Medetomidine hydrochloride (equivalent
More informationStudy the Effect of Dexmedetomidine on Emergence Agitation after Nasal Surgeries
Original Research Article Study the Effect of Dexmedetomidine on Emergence Agitation after Nasal Surgeries G V Krishna Reddy 1*, S. Kuldeep 2, G. Obulesu 3 1 Assistant Professor, Department of Anaesthesiology,
More informationComparison of two doses of intranasal dexmedetomidine as premedication in children
Comparison of two doses of intranasal dexmedetomidine as premedication in children V. Pavithra, M. N. Ramani, S. K. Shah Department of Anaesthesia, B. J. Medical College, Civil Hospital, Ahmedabad, Gujarat,
More informationHemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery
Hemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery Juan F. De la Mora-González *, José A. Robles-Cervantes 2,4, José M. Mora-Martínez 3, Francisco Barba-Alvarez
More informationHaemodynamic and anaesthetic advantages of dexmedetomidine
Haemodynamic and anaesthetic advantages of dexmedetomidine Abstract Rao SH, Assistant Professor Sudhakar B, Associate Professor Subramanyam PK, Professor Department of Anaesthesia and Critical Care, Dr
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Medeson 1 mg/ml solution for injection for dogs and cats [AT, CY, CZ, DE, EL, ES, HR, IT, LT, LV, PL, PT, RO, SI, SK] Medeson,
More informationRajaclimax Kirubahar, Bose Sundari, Vijay Kanna*, Kanakasabai Murugadoss
International Journal of Research in Medical Sciences Kirubahar R et al. Int J Res Med Sci. 2016 Apr;4(4):1172-1176 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160804
More informationQuality of MRI pediatric sedation: Comparison between intramuscular and intravenous dexmedetomidine
Egyptian Journal of Anaesthesia (2013) 29, 47 52 Egyptian Society of Anesthesiologists Egyptian Journal of Anaesthesia www.elsevier.com/locate/egja www.sciencedirect.com Research Article Quality of MRI
More informationDISSOCIATIVE ANESTHESIA
DISSOCIATIVE ANESTHESIA Adarsh Kumar Dissociative anesthesia implies dissociation from the surrounding with only superficial sleep mediated by interruption of neuronal transmission from unconscious to
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, ES,
More informationPreliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit
Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit R. M. Venn, 1 C. J. Bradshaw, 1 R. Spencer, 2 D. Brealey, 3 E. Caudwell, 3 C. Naughton,
More informationAssociate Professor, Department of Anaesthesiology, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India, 2
Original Article DOI: 10.17354/ijss/2016/295 Effect of Intravenous use of Dexmedetomidine on Anesthetic Requirements in Patients Undergoing Elective Spine Surgery: A Double Blinded Randomized Controlled
More informationPAIN Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery
British Journal of Anaesthesia 101 (3): 395 9 (2008) doi:10.1093/bja/aen184 Advance Access publication June 20, 2008 PAIN Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic
More informationRETRACTED. Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery
Journal of Clinical Anesthesia (2006) 18, 422 426 Original contribution Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery Robert J. Frumento MS, MPH, Helene G.
More informationIntraoperative Sedation During Epidural Anesthesia: Dexmedetomidine Vs Midazolam
ISPUB.COM The Internet Journal of Anesthesiology Volume 17 Number 2 Intraoperative Sedation During Epidural Anesthesia: Dexmedetomidine Vs Midazolam M Celik, N Koltka, B Cevik, H Baba Citation M Celik,
More informationA Comparative Evaluation of Intranasal Dexmedetomidine and Intranasal Midazolam for Premedication in Pediatric Surgery
Original Research Article A Comparative Evaluation of Intranasal Dexmedetomidine and Intranasal Midazolam for Premedication in Pediatric Surgery Dr. Shweta Nitturi 1*, Dr. Olvyna D souza 2 1 ICU Junior
More informationComparison of dexmedetomidine and propofol in mechanically ventilated patients with sepsis: A pilot study
Original article Comparison of dexmedetomidine and propofol in mechanically ventilated patients with sepsis: A pilot study Mark B. Sigler MD, Ebtesam A. Islam MD PhD, Kenneth M. Nugent MD Abstract Objective:
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
SUMMARY OF PRODUCT CHARACTERISTICS Revised: September 2015 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
More informationReview article Dexmedetomidine: perioperative applications in children
Pediatric Anesthesia 2010 20: 256 264 doi:10.1111/j.1460-9592.2009.03207.x Review article Dexmedetomidine: perioperative applications in children VIVIAN MAN YING YUEN MBBS,FHKCA,FHKAM,FANZCA* *Department
More informationSusan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA
Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA Disclosures Study and presentation has no commercial bias or interests No financial relationship with a commercial interest, products,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NOSEDORM 5 mg/ml Solution for injection for dogs and cats [DE, ES, FR, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationA comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation
doi:10.1111/j.1365-2044.2009.06226.x ORIGINAL ARTICLE A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation
More informationAustralian College of Veterinary Scientists Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian College of Veterinary Scientists Fellowship Examination June 2011 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours after perusal
More informationAshraf Darwish, Rehab Sami, Mona Raafat, Rashad Aref and Mohamed Hisham
Dexmedetomidine versus Propofol for Monitored Anesthesia Care In Patients Undergoing Anterior Segment Ophthalmic Surgery Under Peribulbar Medial Canthus Anesthesia Ashraf Darwish, Rehab Sami, Mona Raafat,
More informationOriginal Article Effects of low dose midazolam on bradycardia and sedation during dexmedetomidine infusion
Int J Clin Exp Med 2016;9(6):11838-11844 www.ijcem.com /ISSN:1940-5901/IJCEM0020616 Original Article Effects of low dose midazolam on bradycardia and sedation during dexmedetomidine infusion Yun-Sic Bang
More informationAlfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS
Alfaxan (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. NADA 141-342, Approved by FDA ALFAXAN (Schedule: C-IV) (alfaxalone 10 mg/ml) Intravenous injectable anesthetic
More informationDay 90 Labelling, PL LABELLING AND PACKAGE LEAFLET
LABELLING AND PACKAGE LEAFLET A. LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGE : Carton 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs
More informationT u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods
T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous
More informationComparison of dexmedetomidine and propofol for conscious sedation in inguinal hernia repair: A prospective, randomized, controlled trial
Research Report Comparison of dexmedetomidine and propofol for conscious sedation in inguinal hernia repair: A prospective, randomized, controlled trial Journal of International Medical Research 2017,
More informationPremedication with alpha-2 agonists procedures for monitoring anaesthetic
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Premedication with alpha-2 agonists procedures for monitoring anaesthetic Author : Lisa Angell, Chris Seymour Categories :
More informationRole of Dexmedetomidine as an Anesthetic Adjuvant in Laparoscopic Surgery
Role of Dexmedetomidine as an Anesthetic Adjuvant in Laparoscopic Surgery Vaishali Waindeskar, Munir Khan, Shankar Agarwal, M R Gaikwad Department of Anesthesiology, People s College of Medical Sciences
More informationA New Advancement in Anesthesia. Your clear choice for induction.
A New Advancement in Anesthesia Your clear choice for induction. By Kirby Pasloske When using Alfaxan, patients should be continuously monitored, and facilities for maintenance of a patent airway, artificial
More informationDexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery?
Cardiac Intensive Care Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery? Constantinos Chrysostomou, MD; Joan Sanchez De Toledo, MD; Tracy Avolio,
More information1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
PACKAGE LEAFLET FOR: Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, PT, UK] Reanest 1 mg/ml solution for injection for dogs and cats
More informationDiskography is a diagnostic modality used to
Use of Dexmedetomidine for Monitored Anesthesia Care for Diskography in Adolescents James Furstein, CRNA, DNAP Manish Patel, DO Senthilkumar Sadhasivam, MD, MPH Mohamed Mahmoud, MD Procedural sedation
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Xylacare 2% w/v Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition
More informationAustralian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Fellowship Examination June 2016 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours
More informationThe Effects of 2-Adrenergic Receptor Agonist Dexmedetomidine on Hemodynamic Response in Direct Laryngoscopy
The Open Otorhinolaryngology Journal, 2007, 1, 5-11 5 The Effects of 2-Adrenergic Receptor Agonist Dexmedetomidine on Hemodynamic Response in Direct Laryngoscopy Berrin I ik, Mustafa Arslan *, Özgür Özsoylar
More informationDexmedetomidine and its Injectable Anesthetic-Pain Management Combinations
Back to Anesthesia/Pain Management Back to Table of Contents Front Page : Library : ACVC 2009 : Anesthesia/Pain Management : Dexmedetomidine Dexmedetomidine and its Injectable Anesthetic-Pain Management
More informationWhat dose of methadone should I use?
What dose of methadone should I use? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia SPC dose rates for Comfortan dogs: 0.5-1.0 mg/kg SC,
More informationDepartment of Laboratory Animal Resources. Veterinary Recommendations for Anesthesia and Analgesia
Department of Laboratory Animal Resources Guideline Veterinary Recommendations for Anesthesia and Analgesia A. PRINCIPLES OF ANESTHESIA AND ANALGESIA 1. The proper anesthetic and analgesic agents must
More informationOver the past 10 years, there has been an increase in
Dexmedetomidine for Sedation During Noninvasive Ventilation in Pediatric Patients Rasika Venkatraman, MD 1 ; James L. Hungerford, MD 2,3 ; Mark W. Hall, MD 1 ; Melissa Moore-Clingenpeel, MS 1,4 ; Joseph
More informationA comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops
Original Article doi:10.1111/anae.13407 A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops B. L. Li, 1 N. Zhang, 2 J. X. Huang, 1 Q. Q. Qiu,
More informationDexmedetomidine versus ketamine combined with midazolam; a comparison of anxiolytic and sedative premedication in children
BJMP 2011;4(4):a441 Research Article Dexmedetomidine versus ketamine combined with midazolam; a comparison of anxiolytic and sedative premedication in children Mohamed A. Daabiss and Mohamed Hashish ABSTRACT
More informationA SYSTEMATIC REVIEW ON THE USE OF DEXMEDETOMIDINE AS A SOLE AGENT FOR INTRAVENOUS MODERATE SEDATION
A SYSTEMATIC REVIEW ON THE USE OF DEXMEDETOMIDINE AS A SOLE AGENT FOR INTRAVENOUS MODERATE SEDATION by Dr. Samuel Y. Toong A thesis submitted in conformity with the requirements for the degree of Master
More informationNon-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sedadex 0.1 mg/ml solution for injection for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Dexmedetomidine hydrochloride
More informationOriginal Article INTRODUCTION. Abstract
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/305 Comparison between 0.5 µg/kg Dexmedetomidine with 0.5% Lignocaine and 0.5% Lignocaine Alone in Intravenous for
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Narketan-10 100 mg/ml Solution for Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance
More informationDisclosures. Dexmedetomidine: The Good, The Bad and The Delirious. The Delirious. Objectives. Characteristics of Delirium. Definition of Delirium
Dexmedetomidine: The Good, The Bad and The Delirious Disclosures! I have no actual or potential conflict of interest in relation to this presentation. By John J. Bon, Pharm.D., BCPS Lead Clinical Pharmacist,
More informationParthasarathy et al. Sri Lankan Journal of Anaesthesiology: 25(2):76-81(2017)
Comparison of efficacy of intravenous dexmedetomidine with intravenous ketamine in allaying procedural discomfort during establishment of subarachnoid block S Parthasarathy 1*, AJ Charles 2, DR Singh 1,
More informationCase Report Dexmedetomidine as a Procedural Sedative for Percutaneous Tracheotomy: Case Report and Systematic Literature Review
Case Reports in Critical Care Volume 2012, Article ID 659415, 4 pages doi:10.1155/2012/659415 Case Report Dexmedetomidine as a Procedural Sedative for Percutaneous Tracheotomy: Case Report and Systematic
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationEvaluation of efficacy of sedative and analgesic effects of single IV dose of dexmedetomidine in post-operative patients
www.ijpcs.net ABSTRACT Evaluation of efficacy of sedative and analgesic effects of single IV dose of dexmedetomidine in post-operative patients Manasa CR 1 *, Padma L 2, Shivshankar 3, Ranjani Ramanujam
More informationComparison of Clonidine and Dexmedetomidine on Cardiovascular Stability in Laparoscopic Cholecystectomy
Original Article DOI: 10.17354/ijss/2016/185 Comparison of Clonidine and Dexmedetomidine on Cardiovascular Stability in Laparoscopic Cholecystectomy Devang Bharti 1, Juhi Saran 2, Chetan Kumar 3, H S Nanda
More informationDexmedetomidine for Emergence Agitation after Sevoflurane Anesthesia in Preschool Children Undergoing Day Case Surgery: Comparative Dose-Ranging Study
Med. J. Cairo Univ., Vol. 79, No. 2, March: 17-23, 2011 www.medicaljournalofcairouniversity.com Dexmedetomidine for Emergence Agitation after Sevoflurane Anesthesia in Preschool Children Undergoing Day
More informationStudy of Dexmedetomidine as intramuscular premedication in outpatient cataract surgery: A placebo controlled study
Original Research Article Study of Dexmedetomidine as intramuscular premedication in outpatient cataract surgery: A placebo controlled study D. Srinivasa Naik 1, K. Ravi Kumar 1, Surendra Babu 2, R. Pandu
More informationA Comparison of Dexmedetomidine and Midazolam for Sedation in Gynecologic Surgery Under Epidural Anesthesia
Original Article Elmer Press A Comparison of Dexmedetomidine and Midazolam for Sedation in Gynecologic Surgery Under Epidural Anesthesia Yongxin Liang a, b, Miaoning Gu b, Shiduan Wang a, Haichen Chu a,
More informationDr. PratekKoolwal, Dr.BribalBaj, DrKashif M Madani, Dr.MohitSomani, Dr. Vijay Mathur.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-853, p-issn: 2279-861.Volume 14, Issue 7 Ver. VIII (July. 215), PP 84-9 www.iosrjournals.org "Dose related prolongation of hyperbaric
More informationTotal Intravenous Anaesthesia (TIVA) in Veterinary Practice
Total Intravenous Anaesthesia (TIVA) in Veterinary Practice Rukmani Dewangan 1, S. K. Tiwari 2 1, 2 Department of Veterinary Surgery and Radiology, College of Veterinay Science and A.H. Anjora Durg (C.G.),
More informationClinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007
1 / 2007 Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 5 Dexmedetomidine: a new 2-adrenoceptor agonist for modern multimodal anaesthesia in dogs and cats
More informationAustralian and New Zealand College of Veterinary Scientists. Fellowship Examination. Small Animal Surgery Paper 1
Australian and New Zealand College of Veterinary Scientists Fellowship Examination June 2016 Small Animal Surgery Paper 1 Perusal time: Twenty (20) minutes Time allowed: Three (3) hours after perusal Answer
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours
More informationComparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on time to extubation in dogs
Veterinary Anaesthesia and Analgesia, 2016, 43, 86 90 doi:10.1111/vaa.12273 SHORT COMMUNICATION Comparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on
More informationCandidate Name: PRACTICAL Exercise Medications & Injections
PRACTICAL Exercise Medications & Injections VERY IMPORTANT Method: In groups - staggered - PLEASE WAIT YOUR TURN / STAND BACK IF ASKED Do bookwork - work out dosages - 1a / 2a / 3a Got to Medications Table
More informationCheung, CW; Ying, CLA; Chiu, WK; Wong, GTC; Ng, KFJ; Irwin, MG
Title A comparison of dexmedetomidine and midazolam for sedation in third molar surgery Author(s) Citation Cheung, CW; Ying, CLA; Chiu, WK; Wong, GTC; Ng, KFJ; Irwin, MG 11th International Dental Congress
More informationTherapeutics and clinical risk management (2011) Vol.7:291~299. Dexmedetomidine hydrochloride as a long-term sedative.
Therapeutics and clinical risk management (2011) Vol.7:291~299. Dexmedetomidine hydrochloride as a long-term sedative Kunisawa Takayuki Therapeutics and Clinical Risk Management open access to scientific
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Acecare 2mg/ml Solution for Injection for Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution contains
More informationModule C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1)
Module C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1) Module Leader - Elizabeth Armitage-Chan MA Vet MB DipACVA MRCVS RCVS Specialist in Veterinary Anaesthesia The aim of the
More informationNeonates and infants undergoing radiological imaging
Dexmedetomidine for Pediatric Sedation for Computed Tomography Imaging Studies Keira P. Mason, MD* Steven E. Zgleszewski, MD* Jennifer L. Dearden, MD* Raymond S. Dumont, MD* Michele A. Pirich, RN, BSN
More informationComparison of Intensive Care Unit Sedation Using Dexmedetomidine, Propofol, and Midazolam
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/24 Comparison of Intensive Care Unit Sedation Using Dexmedetomidine, Propofol, and Midazolam Gajendra Singh, Kakhandki
More informationDexmedetomidine intravenous sedation using a patient-controlled sedation infusion pump: a case report
Case Report pissn 2383-9309 eissn 2383-9317 J Dent Anesth Pain Med 2016;16(1):55-59 http://dx.doi.org/10.17245/jdapm.2016.16.1.55 Dexmedetomidine intravenous sedation using a patient-controlled sedation
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Anaestamine 100 mg/ml solution for injection Aniketam, 100 mg/ml solution for injection (EE/LT/LV) Aniketam vet., 100 mg/ml
More informationCERTIFICATE IN VETERINARY ANAESTHESIA
WEDNESDAY 28 JULY 2004 PAPER l Candidates are required to answer ALL TEN questions. Allow 12 minutes per question. 1. Briefly describe the local analgesic technique you would use to permit dehorning of
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 38, Pages: *Corresponding author s
Research Article Comparative Study Betweeen Dexmedetomidine and Remifentanyl for Efficient Pain and Ponv Management in Propofol Based Total Intravenous Anesthesia after Laparoscopic Gynaecological Surgeries
More informationBenefits of total intravenous anaesthesia in dogs and cats
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Benefits of total intravenous anaesthesia in dogs and cats Author : KATHERINE ROBSON Categories : Vets Date : November 17,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DEXDOMITOR 0.1 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Excipients:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the Veterinary Medicinal Product Vetofol 10mg/ml Emulsion for Injection for cats and dogs (AT, CY, EE, FI, DE, EL, LV, PT, ES) Norofol 10mg/ml Emulsion for
More informationReview Article Clinical efficacy of dexmedetomidine versus propofol in children undergoing magnetic resonance imaging: a meta-analysis
Int J Clin Exp Med 2015;8(8):11881-11889 www.ijcem.com /ISSN:1940-5901/IJCEM0009563 Review Article Clinical efficacy of dexmedetomidine versus propofol in children undergoing magnetic resonance imaging:
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Intravenous Dexmedetomidine Premedication on Spinal Anaesthesia with Hyperbaric Bupivacaine
More informationTELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2
TELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2 1) Q: What is TELAZOL? A: TELAZOL (tiletamine and zolazepam for injection) is a nonnarcotic, nonbarbiturate, injectable anesthetic
More informationThe comparison of the effects of intravenous ketamine or dexmedetomidine infusion on spinal block with bupivacaine
Clinical Research Article Korean J Anesthesiol 2014 August 67(2): 85-89 http://dx.doi.org/10.4097/kjae.2014.67.2.85 The comparison of the effects of intravenous ketamine or dexmedetomidine infusion on
More informationPeriod of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)
Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency of Bayer's
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ketamidor 100 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Ketamine (as hydrochloride) Excipient:
More informationA randomized control study of dexmedetomidine versus fentanyl as an anesthetic adjuvant in supratentorial craniotomies
ORIGINAL ARTICLE ANAESTHESIA, PAIN & INTENSIVE CARE www.apicareonline.com A randomized control study of dexmedetomidine versus fentanyl as an anesthetic adjuvant in supratentorial craniotomies Amrita Gupta,
More information